---
title: "Hitgen Inc. (688222.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688222.SH.md"
symbol: "688222.SH"
name: "Hitgen Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-20T22:23:02.376Z"
locales:
  - [en](https://longbridge.com/en/quote/688222.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688222.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688222.SH.md)
---

# Hitgen Inc. (688222.SH)

## Company Overview

HitGen Inc. operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally. Its technology platform includes DNA-encoded library technology; fragment-based drug discovery and structure-based drug design technologies; emerging technology platforms for synthetic therapeutic oligonucleotide technology; and targeted protein degradation technology. The company’s product pipeline also includes HG146, a selective HDAC inhibitor for multiple myeloma and solid tumor; HG030, a second generation NTRK/ROS1 inhibitor tablet for solid tumor; HG153 a Menin-MLL tablet; HG248; HG 381, an immune-oncology agonist for cancer, as well as HGP0508, a small molecule for anti-inflammatory therapeutics for inflammation; and HGP1069, a ROCK2 inhibitor eye drop.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | CN Market |
| Website | [www.hitgen.com](https://www.hitgen.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: B (0.35)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 4 / 26 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 35.89% |  |
| Net Profit YoY | 93.65% |  |
| P/B Ratio | 7.48 |  |
| Dividend Ratio | 0.21% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 11519970252.52 |  |
| Revenue | 580402060.33 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 8.59% | B |
| Profit Margin | 21.96% | A |
| Gross Margin | 56.34% | B |
| Revenue YoY | 35.89% | A |
| Net Profit YoY | 93.65% | A |
| Total Assets YoY | 11.25% | B |
| Net Assets YoY | 6.24% | B |
| Cash Flow Margin | 0.00% | D |
| OCF YoY | 35.89% | A |
| Turnover | 0.30 | D |
| Gearing Ratio | 23.26% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Hitgen Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "35.89%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "93.65%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "7.48",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.21%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "11519970252.52",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "580402060.33",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "8.59%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "21.96%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "56.34%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "35.89%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "93.65%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "11.25%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "6.24%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "35.89%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.30",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "23.26%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 94.91 | 15/26 | 113.14 | 100.21 | 87.12 |
| PB | 7.57 | 27/26 | 7.55 | 6.78 | 6.21 |
| PS (TTM) | 20.10 | 27/26 | 22.40 | 20.62 | 18.36 |
| Dividend Yield | 0.21% | 15/26 | 0.27% | 0.25% | 0.21% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | WuXi AppTec (603259.SH) | A | A | C | A | B | B |
| 02 | Pharmaron (300759.SZ) | B | B | C | B | B | B |
| 03 | Chemexpress (688131.SH) | B | B | C | C | B | B |
| 04 | HitGen (688222.SH) | B | A | D | B | C | B |
| 05 | GEMPHARMATECH (688046.SH) | B | B | D | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-12T16:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 2 | 67% |
| Overweight | 1 | 33% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 29.07 |
| Highest Target | 31.60 |
| Lowest Target | 31.60 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688222.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688222.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688222.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**